kegg, founded in 2017, is a health tech startup based in the United States that operates in the Health Care, Health and Wellness, and Medical Devices industries. The company is renowned for its flagship product, keggᵀᴹ, a pioneering fertility tracking device that empowers women with advanced insights into their reproductive health.
Utilizing cutting-edge sensor technology like impedance spectroscopy, kegg gives users a highly accurate forecast of their fertility windows and ovulation, surpassing traditional probability-based methods. This allows women globally to achieve natural conception more efficiently. The device doubles as a kegel tracker, blending fertility monitoring with pelvic health benefits.
The company attracted a $3.00M Seed Round investment on 31 August 2021, with contributions from notable investors such as SOSV, Texas Halo Fund, Althea Ventures, and Ad Astra Ventures. As the demand for precise fertility solutions rises, kegg positions itself as a leader in personalized reproductive healthcare.